Deciphera Pharmaceuticals, Llc
Clinical trials sponsored by Deciphera Pharmaceuticals, Llc, explained in plain language.
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-stage study tested a new drug, DCC-3116, alone or with other targeted therapies, in people with advanced solid tumors that have certain gene mutations (RAS/MAPK pathway). The goal was to find safe doses and see if the drug could shrink tumors. The study was terminated …
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Cancer drug trial halted early after testing on 29 patients
Disease control TerminatedThis study tested a new drug called DCC-3084, alone or with other cancer treatments, in people with advanced solid tumors that have certain gene changes (MAPK pathway). The trial aimed to find safe doses and see if the drug could shrink tumors. It was stopped early after enrollin…
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 27, 2026 23:05 UTC